
Kimberly Chong
Examiner (ID: 8669, Phone: (571)272-3111 , Office: P/1674 )
| Most Active Art Unit | 1635 |
| Art Unit(s) | 1636, 1635, 1674 |
| Total Applications | 2007 |
| Issued Applications | 1153 |
| Pending Applications | 209 |
| Abandoned Applications | 674 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5649721
[patent_doc_number] => 20060135456
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-22
[patent_title] => 'Methods and compositions for RNA interference'
[patent_app_type] => utility
[patent_app_number] => 10/997086
[patent_app_country] => US
[patent_app_date] => 2004-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 67
[patent_figures_cnt] => 67
[patent_no_of_words] => 41276
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0135/20060135456.pdf
[firstpage_image] =>[orig_patent_app_number] => 10997086
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/997086 | Methods and compositions for RNA interference | Nov 22, 2004 | Issued |
Array
(
[id] => 13696
[patent_doc_number] => 07807646
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2010-10-05
[patent_title] => 'SHIP-deficiency to increase megakaryocyte progenitor production'
[patent_app_type] => utility
[patent_app_number] => 10/904667
[patent_app_country] => US
[patent_app_date] => 2004-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9726
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/807/07807646.pdf
[firstpage_image] =>[orig_patent_app_number] => 10904667
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/904667 | SHIP-deficiency to increase megakaryocyte progenitor production | Nov 21, 2004 | Issued |
Array
(
[id] => 7045528
[patent_doc_number] => 20050250123
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-10
[patent_title] => 'Reducing galectin-12 activity to reduce formation of adipocytes'
[patent_app_type] => utility
[patent_app_number] => 10/995793
[patent_app_country] => US
[patent_app_date] => 2004-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 22615
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0250/20050250123.pdf
[firstpage_image] =>[orig_patent_app_number] => 10995793
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/995793 | Reducing galectin-12 activity to reduce formation of adipocytes | Nov 21, 2004 | Abandoned |
Array
(
[id] => 5015785
[patent_doc_number] => 20070258993
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-08
[patent_title] => 'Dna-Carrier Conjugate'
[patent_app_type] => utility
[patent_app_number] => 10/579229
[patent_app_country] => US
[patent_app_date] => 2004-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 13824
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20070258993.pdf
[firstpage_image] =>[orig_patent_app_number] => 10579229
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/579229 | Dna-Carrier Conjugate | Nov 11, 2004 | Abandoned |
Array
(
[id] => 6925947
[patent_doc_number] => 20050239202
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-27
[patent_title] => 'Methods and compositions for inhibiting the function of polynucleotide sequences'
[patent_app_type] => utility
[patent_app_number] => 10/977537
[patent_app_country] => US
[patent_app_date] => 2004-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 15204
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0239/20050239202.pdf
[firstpage_image] =>[orig_patent_app_number] => 10977537
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/977537 | Methods and compositions for inhibiting the function of polynucleotide sequences | Oct 28, 2004 | Abandoned |
Array
(
[id] => 7075268
[patent_doc_number] => 20050148536
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-07
[patent_title] => 'Methods for treating and preventing insulin resistance and related disorders'
[patent_app_type] => utility
[patent_app_number] => 10/977116
[patent_app_country] => US
[patent_app_date] => 2004-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 25439
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20050148536.pdf
[firstpage_image] =>[orig_patent_app_number] => 10977116
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/977116 | Methods for treating and preventing insulin resistance and related disorders | Oct 28, 2004 | Abandoned |
Array
(
[id] => 4471187
[patent_doc_number] => 07943755
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-05-17
[patent_title] => 'Neuron regeneration'
[patent_app_type] => utility
[patent_app_number] => 11/577663
[patent_app_country] => US
[patent_app_date] => 2004-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 12678
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/943/07943755.pdf
[firstpage_image] =>[orig_patent_app_number] => 11577663
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/577663 | Neuron regeneration | Oct 21, 2004 | Issued |
Array
(
[id] => 217285
[patent_doc_number] => 07612195
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-11-03
[patent_title] => 'Retroviral vectors for delivery of interfering RNA'
[patent_app_type] => utility
[patent_app_number] => 10/574416
[patent_app_country] => US
[patent_app_date] => 2004-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 7
[patent_no_of_words] => 7813
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/612/07612195.pdf
[firstpage_image] =>[orig_patent_app_number] => 10574416
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/574416 | Retroviral vectors for delivery of interfering RNA | Oct 20, 2004 | Issued |
Array
(
[id] => 5194380
[patent_doc_number] => 20070082864
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-12
[patent_title] => 'Method for inducing a specific rnai activity in cells and nucleic acids for carrying out said method'
[patent_app_type] => utility
[patent_app_number] => 10/576390
[patent_app_country] => US
[patent_app_date] => 2004-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2986
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20070082864.pdf
[firstpage_image] =>[orig_patent_app_number] => 10576390
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/576390 | Method for inducing a specific rnai activity in cells and nucleic acids for carrying out said method | Oct 18, 2004 | Abandoned |
Array
(
[id] => 7070088
[patent_doc_number] => 20050245473
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-03
[patent_title] => 'Proliferation- and differentiation-modulating agents and uses therefor'
[patent_app_type] => utility
[patent_app_number] => 10/967648
[patent_app_country] => US
[patent_app_date] => 2004-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 27471
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0245/20050245473.pdf
[firstpage_image] =>[orig_patent_app_number] => 10967648
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/967648 | Proliferation- and differentiation-modulating agents and uses therefor | Oct 14, 2004 | Abandoned |
Array
(
[id] => 4682812
[patent_doc_number] => 20080249038
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-09
[patent_title] => 'Bone Morphogenetic Protein (Bmp) 2A and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 10/575121
[patent_app_country] => US
[patent_app_date] => 2004-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 17270
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20080249038.pdf
[firstpage_image] =>[orig_patent_app_number] => 10575121
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/575121 | Bone Morphogenetic Protein (Bmp) 2A and Uses Thereof | Oct 5, 2004 | Abandoned |
Array
(
[id] => 6983849
[patent_doc_number] => 20050153919
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-14
[patent_title] => 'Oligonucleotide compositions and methods for treating disease including inflammatory conditions'
[patent_app_type] => utility
[patent_app_number] => 10/953512
[patent_app_country] => US
[patent_app_date] => 2004-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 19079
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20050153919.pdf
[firstpage_image] =>[orig_patent_app_number] => 10953512
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/953512 | Oligonucleotide compositions and methods for treating disease including inflammatory conditions | Sep 28, 2004 | Issued |
Array
(
[id] => 7010780
[patent_doc_number] => 20050064496
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-24
[patent_title] => 'Methods and compositions for inhibiting the function of polynucleotide sequences'
[patent_app_type] => utility
[patent_app_number] => 10/949845
[patent_app_country] => US
[patent_app_date] => 2004-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 15208
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20050064496.pdf
[firstpage_image] =>[orig_patent_app_number] => 10949845
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/949845 | Methods and compositions for inhibiting the function of polynucleotide sequences | Sep 23, 2004 | Abandoned |
Array
(
[id] => 7010773
[patent_doc_number] => 20050064489
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-24
[patent_title] => 'Engineered U6 and H1 promoters'
[patent_app_type] => utility
[patent_app_number] => 10/947035
[patent_app_country] => US
[patent_app_date] => 2004-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 5476
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20050064489.pdf
[firstpage_image] =>[orig_patent_app_number] => 10947035
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/947035 | Engineered U6 and H1 promoters | Sep 21, 2004 | Abandoned |
Array
(
[id] => 6983848
[patent_doc_number] => 20050153918
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-14
[patent_title] => 'Methods and compositions relating to hnRNP A1, A1B, A2, and B1 nucleic acid molecules'
[patent_app_type] => utility
[patent_app_number] => 10/943441
[patent_app_country] => US
[patent_app_date] => 2004-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 31673
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20050153918.pdf
[firstpage_image] =>[orig_patent_app_number] => 10943441
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/943441 | Methods and compositions relating to hnRNP A1, A1B, A2, and B1 nucleic acid molecules | Sep 16, 2004 | Abandoned |
Array
(
[id] => 7195863
[patent_doc_number] => 20050164234
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-28
[patent_title] => 'Methods of using mammalian RNase H and compositions thereof'
[patent_app_type] => utility
[patent_app_number] => 10/943194
[patent_app_country] => US
[patent_app_date] => 2004-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 34437
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0164/20050164234.pdf
[firstpage_image] =>[orig_patent_app_number] => 10943194
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/943194 | Methods of using mammalian RNase H and compositions thereof | Sep 15, 2004 | Abandoned |
Array
(
[id] => 5726830
[patent_doc_number] => 20060057590
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-16
[patent_title] => 'RNA probes'
[patent_app_type] => utility
[patent_app_number] => 10/940537
[patent_app_country] => US
[patent_app_date] => 2004-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2661
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0057/20060057590.pdf
[firstpage_image] =>[orig_patent_app_number] => 10940537
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/940537 | RNA probes | Sep 13, 2004 | Abandoned |
Array
(
[id] => 6990865
[patent_doc_number] => 20050089902
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-28
[patent_title] => 'Methods and compositions for siRNA expression'
[patent_app_type] => utility
[patent_app_number] => 10/932408
[patent_app_country] => US
[patent_app_date] => 2004-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 10342
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0089/20050089902.pdf
[firstpage_image] =>[orig_patent_app_number] => 10932408
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/932408 | Methods and compositions for siRNA expression | Aug 31, 2004 | Abandoned |
Array
(
[id] => 7206022
[patent_doc_number] => 20050043220
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-24
[patent_title] => 'Methods and compositions for treating macular degeneration'
[patent_app_type] => utility
[patent_app_number] => 10/928533
[patent_app_country] => US
[patent_app_date] => 2004-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10557
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0043/20050043220.pdf
[firstpage_image] =>[orig_patent_app_number] => 10928533
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/928533 | Methods and compositions for treating macular degeneration | Aug 26, 2004 | Abandoned |
Array
(
[id] => 6944718
[patent_doc_number] => 20050196767
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-08
[patent_title] => 'RNA interference mediated inhibition of GRB2 associated binding protein (GAB2) gene expression using short interfering nucleic acis (siNA)'
[patent_app_type] => utility
[patent_app_number] => 10/923380
[patent_app_country] => US
[patent_app_date] => 2004-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 65321
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20050196767.pdf
[firstpage_image] =>[orig_patent_app_number] => 10923380
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/923380 | RNA interference mediated inhibition of GRB2 associated binding protein (GAB2) gene expression using short interfering nucleic acis (siNA) | Aug 19, 2004 | Abandoned |